Document is current

Article History

Received: 15 June 2022

Accepted: 11 August 2022

First Online: 30 August 2022

Declarations

:

: SWG provided consultancy advice for MSD R&D, Chugai Pharmaceutical Co., and BioHaven Pharmaceuticals, but these activities had no bearing on this work. All authors state that they have no conflicts of interest to declare.

: This study was approved by the institutional ethics review board of Shanghai OB/GYN Hospital, Fudan University (No. 2020-75).

: All subjects enrolled in this study signed an informed consent for all the procedures and to allow data collection and analysis for research purposes.

: All authors approved this manuscript and consented for publication.

: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and its later amendments. Informed consent was obtained from all patients for being included in the study. The study was approved by the institutional ethics review board of Shanghai OB/GYN Hospital, Fudan University (No. 2020-75). Each patient enrolled in this study signed an informed consent for all the procedures and to allow data collection and analysis for research purposes.